|
Lymphoma Clinical Trials Data presented on Clinical Trials Search is not designed to be a substitute for qualified healthcare advice, visits or professional assistance with a genuine physician. We are not docs. Always consult your dr. on Lymphoma conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Lymphoma Clinical research trials and Lymphoma medical trials occur in a lot of of places throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The propose of the studies / undertakings is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector corporations to locate remedies for all varieties of circumstances, like Lymphoma. Lymphoma Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment alternatives before they are available to the general public. Many times the participants acquire professional assistance for free of charge, and occasionally they are compensated for their time. Occasionally there is a cost for a Lymphoma clinical trial. Participants oftentimes receive the finest healthcare available for their Lymphoma condition. Hazards are a reality, nonetheless, and could include extra or frequent dr. trips, medical risks (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > Clinical Trials by Conditions > "L" Clinical Trial Conditions > Lymphoma Clinical Trials
Lymphoma Clinical Trials
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Condition: cancer_institute_of_new_jersey_clinical_trials.html
Cancer Institute of New Jersey
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
506U78 in Treating Patients With Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
A Phase I Study of a Histone Deacetylase Inhibitor, MS-275, with an Oral 28-Day Dosing Schedule in Refractory Solid Tumors and Lymphomas
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
A Phase I Study of Infusional Chemotherapy with the P-Glycoprotein Antagonist PSC 833
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
A Phase I Study of Infusional Paclitaxel with the P-Glycoprotein Antagonist PSC 833
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients with Refractory Metastatic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
A Phase I Study of the Combination of Continuous Daily CAI and Intermittent Paclitaxel in Adult Patients with Refractory Cancers or Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
A Phase I Study of Weekly Gemcitabine Given in Combination with Infusional Fluorouracil and Oral and Intravenous Calcium Leucovorin in Adult Cancer Patients
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
A Phase I Trial of 5-Flouroucacil Given with 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients with Solid Tumors
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
A Phase I Trial of Continuous Infusion UCN-01 in Patients with Refractory Neoplasms
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Active Specific Immunotherapy for Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Condition: scripps_clinic_clinical_trials.html
Scripps Clinic
Arsenic Trioxide to Treat Children with Leukemia or Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
Condition: washington_university_barnard_cancer_center_clinical_trials.html
Washington University Barnard Cancer Center
Autologous Platelets
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center
Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
Condition: sidney_kimmel_cancer_center_clinical_trials.html
Sidney Kimmel Cancer Center
BCX-1777 in Treating Patients With Refractory Hematologic Cancer
Condition: biocryst_pharmaceuticals_clinical_trials.html
BioCryst Pharmaceuticals
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Beta Alethine in Treating Patients With Low-Grade Lymphoma
Condition: lifetime_pharmaceuticals_clinical_trials.html
LifeTime Pharmaceuticals
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
Condition: midwestern_regional_medical_center_clinical_trials.html
Midwestern Regional Medical Center
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Biological Therapy in Treating Patients With Lymphoma or Lymphoproliferative Disease
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center
Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma
Condition: ireland_cancer_center_clinical_trials.html
Ireland Cancer Center
BMS-247550 in Treating Patients With Advanced Cancers
Condition: university_of_texas_clinical_trials.html
University of Texas
BMS-247550 in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
Condition: kaplan_cancer_center_clinical_trials.html
Kaplan Cancer Center
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Condition: university_of_maryland_greenebaum_cancer_center_clinical_trials.html
University of Maryland Greenebaum Cancer Center
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
Condition: national_institute_on_aging_nia_clinical_trials.html
National Institute on Aging (NIA)
Bryostatin 1 Plus Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma
Condition: massey_cancer_center_clinical_trials.html
Massey Cancer Center
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
Condition: pediatric_brain_tumor_consortium_clinical_trials.html
Pediatric Brain Tumor Consortium
Campath-1H and EPOCH to Treat non-Hodgkin's T- and NK-Cell Lymphomas
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation
Condition: university_of_maryland_greenebaum_cancer_center_clinical_trials.html
University of Maryland Greenebaum Cancer Center
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Chemotherapy Related Anemia
Condition: amgen_clinical_trials.html
Amgen
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma
Condition: university_of_chicago_cancer_research_center_clinical_trials.html
University of Chicago Cancer Research Center
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Combination Chemotherapy Followed by Donor Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Genetic Disorders
Condition: herbert_irving_comprehensive_cancer_center_clinical_trials.html
Herbert Irving Comprehensive Cancer Center
Lymphoma Clinical Trials
|
|
|
|
|
|
Lymphoma Clinical Trials by State:
Alabama
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Other "L" Clinical Trials Conditions:
L1 Adult Acute Lymphoblastic Leukemia
L1 Childhood Acute Lymphoblastic Leukemia
L2 Adult Acute Lymphoblastic Leukemia
L2 Childhood Acute Lymphoblastic Leukemia
L3 Adult Acute Lymphoblastic Leukemia
L3 Childhood Acute Lymphoblastic Leukemia
Labor Stage, Third
Labor, Premature
Lacrimal Apparatus Disease
Lactic Acidosis
Lafora Disease
Lambert-Eaton Myasthenic Syndrome
Lamellar Ichthyosis
Langerhans Cell Histiocytosis
Language Delay
Language Disorder
Language Disorders
Large Cell Lung Cancer
Laryngeal Cancer
Laryngeal Disease
Laryngeal Neoplasm
Larynx Cancer
Late Onset Alzheimer Disease
Lead Poisoning
Learning Disorders
Left Ventricular Ejection Fraction Less Than Or Equal To 35%
Left Ventricular Hypertrophy
Leg Ulcers
Leiomyoma
Leiomyomatosis
Leiomyosarcoma
Leishmaniasis
Leishmaniasis, Visceral
Lennox-Gastaut Syndrome
Lens Disease
Lentigo
Leptomeningeal Metastases
Lesch-Nyhan Syndrome
Leukemia
Leukemia, B-Cell, Chronic
Leukemia, Hairy Cell
Leukemia, Lymphoblastic, Acute
Leukemia, Lymphocytic
Leukemia, Lymphocytic, Acute
Leukemia, Lymphocytic, Acute, L2
Leukemia, Lymphocytic, Chronic
Leukemia, Lymphocytyc
Leukemia, Myelocytic, Acute
Leukemia, Myeloid
Leukemia, Myeloid, Aggressive-Phase
Leukemia, Myeloid, Chronic
Leukemia, Myeloid, Chronic-Phase
Leukemia, Myeloid, Philadelphia-Positive
Leukemia, Myelomonocytic, Chronic
Leukemia, Nonlymphocytic, Acute
Leukemia, T-Cell
Leukemia,myeloid, Chronic
Leukemia,myeloid,philadelphia-Positive
Leukocyte Adhesion Deficiency Syndrome
Leukocyte Disorder
Leukocyte-Adhesion Deficiency Syndrome
Leukodystrophy, Globoid Cell
Leukoencephalopathy, Progressive Multifocal
Leukopheresis
Leukoplakia
Lichen Planus
Limited Stage Small Cell Lung Cancer
Lip And Oral Cavity Cancer
Lip Neoplasms
Lipid Metabolism, Inborn Errors
Lipodystrophy
Lipoidosis
Liposarcoma
Liver
Liver And Intrahepatic Biliary Tract Cancer
Liver Cancer
Liver Cirrhosis
Liver Cirrhosis, Biliary
Liver Disease
Liver Diseases
Liver Dysfunction
Liver Fibrosis
Liver Metastases
Liver Metastasis
Liver Neoplasm
Liver Neoplasms
Liver Transplantation
Lobular Breast Carcinoma In Situ
Localized Extrahepatic Bile Duct Cancer
Localized Gallbladder Cancer
Localized Malignant Mesothelioma
Localized Osteosarcoma
Localized Resectable Adult Primary Liver Cancer
Localized Resectable Neuroblastoma
Localized Transitional Cell Cancer Of The Renal Pelvis And Ureter
Localized Tumors Of The Ewing's Family
Localized Unresectable Adult Primary Liver Cancer
Localized Unresectable Neuroblastoma
Loiasis
Long Qt Syndrome
Long-Term Effects Secondary To Cancer Therapy In Children
Low Back Pain
Low Vision
Low-Grade Childhood Cerebral Astrocytoma
Low-Grade Lymphoma
Low-Grade Salivary Gland Carcinoma
Low-Grade Salivary Gland Mucoepidermoid Carcinoma
Lower Back Pain
Lower Extremity Ulcers
Lung Cancer
Lung Disease
Lung Diseases
Lung Diseases, Fungal
Lung Diseases, Interstitial
Lung Diseases, Obstructive
Lung Infection
Lung Metastases
Lung Neoplasm
Lung Neoplasms
Lung Transplant
Lupus
Lupus Erythematosus
Lupus Erythematosus, Systemic
Lupus Glomerulonephritis
Lupus Nephritis
Lyme Arthritis
Lyme Disease
Lyme Neuroborreliosis
Lymphadenopathy
Lymphangioleiomyomatosis
Lymphangioma
Lymphangiomyomatosis
Lymphatic Disease
Lymphatic Diseases
Lymphedema
Lymphoblastic Leukemia
Lymphoblastic Lymphoma
Lymphocytic Leukemia
Lymphocytic Lymphoma
Lymphocytosis
Lymphoid Cancer
Lymphoma
Lymphoma, Aids-Related
Lymphoma, B-Cell
Lymphoma, Follicular
Lymphoma, Large-Cell
Lymphoma, Large-Cell, Diffuse
Lymphoma, Low-Grade
Lymphoma, Malignant
Lymphoma, Mantle-Cell
Lymphoma, Mixed-Cell, Follicular
Lymphoma, Non-Hodgkin
Lymphoma, Non-Hodgkin's
Lymphoma, Small Cleaved-Cell, Follicular
Lymphoma, Small Lymphocytic
Lymphoma, Small Noncleaved-Cell
Lymphoma, T-Cell
Lymphoma, T-Cell, Cutaneous
Lymphomas
Lymphomatoid Granulomatosis
Lymphopenia
Lymphoproliferative Disorder
Lymphoproliferative Disorders
Lysosomal Storage Disease
Lysosomal Storage Diseases
|
|
|
